Interestingly, chol-targeting agents inhibit Fas/CD95 aggregation in rafts and apoptosis induced by edelfosine in multiple myeloma cells both in vitro and in vivo (Gajate and Mollinedo, 2001; Gajate and Mollinedo, 2007). This evidence concerns the gene FAS and AL amyloidosis.